Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test
In the first of two Phase 3 tests, Ocular Therapeutix’s Axpaxli met the main goal…
Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test
In the first of two Phase 3 tests, Ocular Therapeutix’s Axpaxli met the main goal of helping maintain vision in patients with the wet form of age-related macular degeneration. The Ocular drug was compared to Eylea, a blockbuster wet AMD drug marketed by Regeneron Pharmaceuticals and Bayer. The post Ocular Therapeutix Eyes FDA Filing After…
Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption
Regulatory frameworks are no longer simply gatekeepers of safety; they increasingly help ensure that new technologies are easier to understand, simpler to use, and more compatible with real-world healthcare settings. The post Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption appeared first on MedCity News.
The Future of Pharmacy is Now – Health Systems Must Act to Drive Innovation, Access and Sustainability
By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it. The post The Future of Pharmacy is Now – Health Systems Must Act to Drive Innovation, Access and Sustainability appeared first on MedCity News.
La respuesta del equipo de Trump a los aumentos de las primas de ACA: cobertura catastrófica
El gobierno de Trump presentó un amplio paquete de propuestas regulatorias que cambiarían de manera sustancial la oferta de planes de salud en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA) el próximo año. Según el gobierno, el objetivo es ofrecer más opciones y primas más bajas. Sin embargo,…
Trump Required Hospitals To Post Their Prices for Patients. Mostly It’s the Industry Using the Data.
Republicans think patients should be shopping for better health care prices. The party has long pushed to give patients money and let consumers do the work of reducing costs. After some GOP lawmakers closed out 2025 advocating to fund health savings accounts, President Donald Trump introduced his Great Healthcare Plan, which calls for, among other…
Listen: Why Do I Need Prior Authorization?
Listen in as “Life Kit” host Marielle Segarra and health reporter Sarah Boden untangle the red tape that can make the prior authorization process frustrating. When the doctor says you need a prescription or treatment, sometimes you need approval from your health insurance first. That’s called prior authorization. Without that sign-off, insurance won’t pay. What…
Sofia Noori, Nema Health
Nema Health has cracked the code on PTSD and has an amazing study showing that their technique of intensive cognitive processing therapy is over 99% effective in flat out curing it in under a month. CEO psychiatrist Sofia Noori took me through what PTSD is, a full demo of how their solution works, and showed…
Something Democrats and Republicans agree on: Dislike for prior authorization
That is the findings from a KFF Health Tracking Poll out this month. The survey examines which aspects of accessing care and health insurance are the biggest problem for insured adults. The survey finds that 69% of adults believe prior authorization is a burden. Specifically, the survey asks “When it comes to getting health care,…
Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA
The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. Analysts say it’s a surprising delay considering bitopertin is one of the first drugs in a new FDA pilot program that speeds up regulatory review of medicines deemed critical for national security or…
NYU Langone Health: We’re Close to Clinical AI with No Human in the Loop
Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, with algorithms soon able to manage routine tasks like blood pressure medication titration and diabetic retinopathy screening without human oversight. They argue automation is not just about efficiency, but also a practical and necessary…
